PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | NEJM
IJMS | Free Full-Text | Old and New Blood Markers in Human Colorectal Cancer
Time to lowest postoperative carcinoembryonic antigen level is predictive on survival outcome in rectal cancer | Scientific Reports
Comparison of Predicted Probabilities of Proportional Hazards Regression and Linear Discriminant Analysis Methods Using a Colore
Colorectal cancer survival rates in Ghana: A retrospective hospital-based study | PLOS ONE
Immunohistochemical Markers as Predictors of Histopathologic Response and Prognosis in Rectal Cancer Treated with Preoperative Adjuvant Therapy: State of the Art
Circulating tumor cells in the early detection of human cancers
.jpg "Naples Prognostic Score Is a Useful Prognostic Marker in Pat... : Diseases of the Colon & Rectum")
Naples Prognostic Score Is a Useful Prognostic Marker in Pat... : Diseases of the Colon & Rectum
Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges - ScienceDirect
Cancers | Free Full-Text | Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century
The DCC Protein and Prognosis in Colorectal Cancer | NEJM
Full text - PDF - The National Cancer Institute
Integrated analysis of RNA-binding proteins in human colorectal cancer | World Journal of Surgical Oncology | Full Text
The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients | British Journal of Cancer
Frontiers | High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer
PDF) Prognostic factors in the patients with T2N0M0 colorectal cancer
Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey | Scientific Reports
Cancers | Free Full-Text | Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
Colon Cancer Treatment (PDQ®)–Health Professional Version - NCI
Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
The impact of tumour pH on cancer progression: strategies for clinical intervention
Cancers | Free Full-Text | Review of Histopathological and Molecular Prognostic Features in Colorectal Cancer
Accurate diagnosis and prognosis prediction of gastric cancer using deep learning on digital pathological images: A retrospective multicentre study - eBioMedicine
Rectal Cancer Treatment (PDQ®)–Health Professional Version - NCI
IJMS | Free Full-Text | Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer
Global colorectal cancer burden in 2020 and projections to 2040 - ScienceDirect
